We may have a new player in the form of megadoses of vitamine c.
All depends on why and how it works and the limitations of what it does. If it can stop sepsis in its tracks than it is a very real danger to parts of MSB's and Novartis future business given the small cost of it.
This is something we should keep track of
Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-180
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
-0.040(1.71%) |
Mkt cap ! $2.943B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.36 | $2.30 | $6.598M | 2.848M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 47739 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.32 | 28495 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2025 (20 minute delay) ? |
| MSB (ASX) Chart |